5321-59-5

Usage

Uses

Used in Organic Synthesis:
2-Pyrazin-2-yl-ethylamine is used as a building block for the synthesis of heterocyclic and aromatic compounds, contributing to the development of new organic molecules with potential applications in various industries.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 2-Pyrazin-2-yl-ethylamine is utilized as a precursor in the development of new drugs, leveraging its biological activities and pharmacological properties to create innovative therapeutic agents.
Used in Coordination Chemistry:
2-Pyrazin-2-yl-ethylamine is employed as a ligand in coordination chemistry, facilitating the formation of metal complexes that can have specialized properties and applications.
Used in Asymmetric Synthesis:
As a chiral auxiliary, 2-Pyrazin-2-yl-ethylamine is used in asymmetric synthesis to produce enantiomerically pure compounds, which are essential in the creation of pharmaceuticals and agrochemicals with specific biological activities.
Used in Agrochemical Development:
In the agrochemical industry, 2-Pyrazin-2-yl-ethylamine serves as a precursor for the development of new pesticides and other agricultural chemicals, potentially enhancing crop protection and yield.

InChI:InChI=1/C6H9N3/c7-2-1-6-5-8-3-4-9-6/h3-5H,1-2,7H2

Upstream product

• 6705-34-6 3-(2-pyrazinyl)propanoic acid 
• 94777-13-6 3-pyrazinyl-propionic acid amide 

Downstream Products

• 1421921-74-5 2-[4-({(E)-[ethyl(methyl)amino]methylidene}amino)-2,5-dimethylbenzyl]-N-[2-(pyrazin-2-yl)ethyl]-1,3-thiazole-4-carboxamide 
• 1198116-53-8 3-oxo-2-(2-pyrazin-2-ylethyl)-N-[[4-(trifluoromethoxy)phenyl]methyl]-1H-isoindole-1-carboxamide 

Relevant academic research and scientific papers

Bicyclic fibrinogen antagonists

This invention relates to compounds of the formulae: wherein A1is O, S, N—R1or CHR1; A4is N—R4or CHR4; R2is a sidechain containing an acid or ester group; R1, R4and R5are substituents such as H, alkyl and aryl alkyl, and R6is a sidechain containing a nitrogen group; and pharmaceutically acceptable salts thereof, which are effective for inhibiting platelet aggregation, pharmaceutical compositions for effecting such activity, and a method for inhibiting platelet aggregation.

Epoxysuccinamide derivative or salt thereof

PCT No. PCT/JP98/01778 Sec. 371 Date Dec. 17, 1998 Sec. 102(e) Date Dec. 17, 1998 PCT Filed Apr. 17, 1998 PCT Pub. No. WO98/47887 PCT Pub. Date Oct. 29, 1998The invention relates an epoxysuccinamide derivative represented by a formula (I): wherein R1 represents a hydrogen atom, an alkyl or aminoalkyl group, R2 represents an aminoalkyl group which May be substituted, an aryl group which may be substituted, a heterocyclic group which may be substituted, an aralkyl group which may be substituted, or an alkyl group substituted by a heterocyclic ring which may be substituted, or R1 and R2 may form a nitrogen-containing heterocyclic ring, which may be substituted, together with the adjacent nitrogen atoms, and R3 and R4 are the same or different from each other and independently represent a hydrogen atom, or an alkyl or aralkyl group, or a salt thereof, a preparation process thereof, and a medicine comprising such a derivative or salt as an active ingredient. This compound has a specific inhibitory activity for cathepsin L and family enzymes thereof, and is useful as an agent for preventing and treating metabolic osteopathy such as osteoporosis and hypercalcemia.